PATENT CLAIM ANALYSIS

Application Number: 15914141
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "001000"]

Abstract:
Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.

Claim (Index 7):
The method according to  claim 1  wherein the dose of dronedarone administered per day, orally, is less than or equal 800 mg, measured in base form, and taken in one or more intakes.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.32143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13847159', '12425125', '13172984', '12972949', '13907349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.765201582027083
- 35 USC 102 Novelty (BERT): 0.6194583631917413
- Combined Prediction Score: 0.7506272601435489
- Mean Citation Score: 390.552892
- Max Citation Score: 546.17175
- Similarity Product: 535.3345619518608

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test